Bridge bio stock price
WebApr 12, 2024 · 7 Wall Street research analysts have issued twelve-month price targets for BridgeBio Pharma's stock. Their BBIO share price forecasts range from $18.00 to … WebAnalyst Ratings Average price target from 9 ratings: $ 25.75 Average score: Sell Under Hold Over Buy Full Ratings Open $13.60 Previous Close- YTD Change 95.54% 12 …
Bridge bio stock price
Did you know?
WebApr 9, 2024 · The stock was sold at an average price of $11.01, for a total transaction of $1,321,200.00. BridgeBio Pharma Trading Up 0.5 % Shares of BBIO stock opened at $15.61 on Friday. WebBridgeBio Pharma (BBIO) (Delayed Data from NSDQ) $15.66 USD +0.48 (3.16%) Updated Apr 13, 2024 04:00 PM ET After-Market: $15.67 +0.01 (0.06%) 7:58 PM ET Add to portfolio Zacks Rank: 3-Hold 3 Style...
WebFeb 15, 2024 · BridgeBio joined the Nasdaq back in 2024 via one of the largest biotech IPOs of the year, which raised >$300m via the issuance of 20.5m shares priced at $17 … WebThe analyst firm set a price target for 23.00 expecting BBIO to rise to within 12 months (a possible 38.72 % upside ). 10 analyst firms have reported ratings in the last year. Q …
WebOct 10, 2024 · Early Stage VC (Series A) 10-Oct-2024. $43.5M. $43.5M. 000.00. Completed. Clinical Trials - General. To view Ribon Therapeutics’s complete valuation and funding history, request access ». WebIn the last 3 months, 5 analysts have offered 12-month price targets for BridgeBio Pharma. The company has an average price target of $25.2 with a high of $29.00 and a low of $19.00. Below is a ...
WebApr 14, 2024 · The stock was sold at an average price of $11.01, for a total transaction of $672,050.40. Following the sale, the chief financial officer now directly owns 219,184 …
WebDec 14, 2024 · Get the latest BridgeBio Pharma Inc. (BBIO) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. cyklokapron fachinformationWebThe 50-day moving average is a frequently used data point by active investors and traders to ... cykloftyalWebLatest On BridgeBio Pharma Inc ALL CNBC INVESTING CLUB PRO Content From Our Affiliates J.P. Morgan Sticks to Its Buy Rating for BridgeBio Pharma (BBIO) March 31, … cyklo helmy forceWebApr 10, 2024 · BridgeBio Pharma NasdaqGS:BBIO Stock Report Last Price US$13.55 Market Cap US$2.2b 7D -3.6% 1Y 21.6% Updated 19 Mar, 2024 Data Company Financials + 10 Analysts BBIO Stock Overview BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. About the company … cyklohexans konformationWebBBIO - BridgeBio Pharma Inc Stock quote - CNNMoney.com BridgeBio Pharma Inc (NASDAQ:BBIO) Real-Time Quotes 15.64 Delayed Data As of Apr 06 +0.11 / +0.71% … cyklofosfamid cenaWebStock Quote & Chart Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. … cykloheksan + cl2WebApr 13, 2024 · In the last 3 months, 5 analysts have offered 12-month price targets for BridgeBio Pharma. The company has an average price target of $25.2 with a high of $29.00 and a low of $19.00. Below is a ... cyklokapron for allergic reaction